| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President and CEO
1 company
Marshall Fordyce is President and CEO at VERA. Marshall Fordyce's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $7.2M at current prices.
Historically, Marshall Fordyce's trades have earned a strong insider score of 74/100 across 30 rated trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +10.9%.
The VERA filings lean toward selling, a net 581,690 shares.
Marshall Fordyce has 36 Form 4 filings on record from May 2021 to September 2026, all as President and CEO at Vera Therapeutics (VERA), 2021–2026.
The 166 reported transactions were 85 open-market sales, 71 option exercises, 6 option or other derivative awards and 4 stock awards.
Counted by filing, the open-market trades come to no purchases and 27 sales worth about $20.4M.
The largest open-market sale was 46,250 shares of VERA at an average $42.30 on July 7, 2026, about $2.0M.
19 of the 21 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 2 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 18,500 | $37.00 | $684,500.00 | -7.3% | - | - | |
| Sep 2, 2026 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 18,500 | $35.12 | $649,642.30 | -7.3% | - | - | |
| Jul 7, 2026 | VERA Vera Therapeutics, Inc. | President and CEO | Sell10b5-1 | 46,250 | $42.30 | $1,956,187.12 | -23.3% | -30.6% | - | |
| Jun 23, 2026 | VERA Vera Therapeutics, Inc. | President and CEO | Sell10b5-1 | 18,500 | $37.93 | $701,769.25 | -8.5% | -10.3% | - | |
| May 12, 2026 | VERA Vera Therapeutics, Inc. | President and CEO | Sell10b5-1 | 18,500 | $36.74 | $679,747.06 | -7.9% | -14.0% | - | |
| Apr 14, 2026 | VERA Vera Therapeutics, Inc. | President and CEO | Sell10b5-1 | 22,951 | $44.05 | $1,011,050.80 | -8.9% | -6.4% | - | |
| Feb 23, 2026 | VERA Vera Therapeutics, Inc. | President and CEO | Sell | 16,925 | $41.98 | $710,577.51 | -6.2% | -18.4% | - | |
| Feb 26, 2025 | VERA Vera Therapeutics, Inc. | President and CEO | Sell10b5-1 | 19,688 | $27.78 | $546,913.71 | -8.8% | -31.4% | +52.4% | |
| Jan 8, 2025 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 17,500 | $41.74 | $730,535.37 | -10.9% | -55.3% | +13.0% | |
| Dec 18, 2024 | VERA Vera Therapeutics, Inc. | President and CEO | Sale+OE10b5-1 | 17,500 | $43.07 | $753,679.56 | -16.9% | -33.9% | +15.3% |